Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04069936
Title Marrow Infiltrating Lymphocytes - Non-Small Cell Lung Cancer (MILs - NSCLC) Alone or in Combination With Pembrolizumab in Advanced Unresectable or Metastatic NSCLC
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors WindMIL Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
University of California - Los Angeles Los Angeles California 90095 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Emory University Atlanta Georgia 30322 United States Details
Karmanos Cancer Center Detroit Michigan 48201 United States Details
Washington University Saint Louis Missouri 63110 United States Details
University of Nebraska Medical Center Omaha Nebraska 68198 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field